SMC1 promotes epithelial-mesenchymal transition in triple-negative breast cancer through upregulating Brachyury

Oncology Reports
Kaichun LiYajie Wang

Abstract

Triple-negative breast cancer (TNBC) is a special subtype of breast cancer, which is characterized by the negative form of estrogen receptor (ER), progesterone receptor (PR) and human epithelial growth factor receptor 2 (HER2). TNBC accounts for ~15% of all breast cancer forms, and often leads to high mortality and poor prognosis. Structural maintenance of chromosome 1 (SMC1) is a subunit of the cohesion protein complex. Brachyury is a protein that is encoded by the T gene in humans, which is a transcription factor within the T-box complex of genes. Epithelial-mesenchymal transition (EMT) is a ubiquitous process in the body, and in particular, induces metastasis and the proliferation of cancer cells. In the present study, we found that SMC1 expression in TNBC tissues exceeded its expression in adjacent non-tumor tissues. Similarly, the expression of SMC1 in TNBC cell lines (hs578T and HCC1937) was found to be higher than in MCF10a and MCF7 cells. Subsequently, SMC1 was overexpressed and silenced in hs578T and HCC1937 cells through plasmid and siRNA transfection, respectively. The results showed that the high expression of SMC1 often promoted EMT, accompanied by the enhanced expression of Brachyury. Besides, upregulated expressi...Continue Reading

References

Oct 13, 2001·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·P Savagner
Dec 31, 2003·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Chris ShowellFrank L Conlon
Jun 15, 2005·Annual Review of Biochemistry·Kim Nasmyth, Christian H Haering
Nov 16, 2005·Annual Review of Genetics·L A NaicheVirginia E Papaioannou
Jan 18, 2006·Virchows Archiv : an International Journal of Pathology·Gou YamamotoTetsuhiko Tachikawa
Feb 24, 2006·Nature Reviews. Molecular Cell Biology·Jean Paul Thiery, Jonathan P Sleeman
Apr 25, 2006·Nature Reviews. Molecular Cell Biology·Tatsuya Hirano
May 26, 2006·Nature·Gerhard Christofori
Jun 3, 2009·The Journal of Clinical Investigation·Raghu Kalluri
Jun 3, 2009·The Journal of Clinical Investigation·Hervé AcloqueM Angela Nieto
Oct 6, 2009·Nature Genetics·Xiaohong R YangMichael J Kelley
Dec 1, 2009·Cell·Jean Paul ThieryM Angela Nieto
Jan 15, 2010·The Journal of Clinical Investigation·Romaine I FernandoClaudia Palena
Aug 6, 2010·American Journal of Hematology·Julien RocquainMax Chaffanet
Jan 12, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Nerbil KilicUdo Schumacher
Sep 24, 2011·Molecular Cancer Research : MCR·Jenny M RhodesJulia A Horsfield
Mar 29, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Otto Metzger-FilhoMartine Piccart-Gebhart
Apr 4, 2012·British Journal of Nursing : BJN·Justin Stebbing, Paul Ellis
May 18, 2012·Genes & Cancer·Valeria OssovskayaNikolai Daraselia
Sep 6, 2012·Development·Jormay Lim, Jean Paul Thiery
May 30, 2013·PloS One·Sushma YadavSanjay Awasthi
Jun 19, 2013·PloS One·Magdalena LaugschRolf Jessberger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

© 2022 Meta ULC. All rights reserved